Is Spyre Therapeutics, Inc. (SYRE) a Buy, Sell, or Hold?
NASDAQ : SYRE
Spyre Therapeutics, Inc.
$102.07 USD
$3.12 (3.15%)
- Volume
- 1.52M
- Average Volume
- 1.39M
- Market Capitalization
- $6.17B
- P/E Ratio
- -46.82
- Dividend Yield
- 0.00%
- Price Target
- $100.00
- Year High
- $105.09
- Year Low
- $14.51
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $8.97
SYRE vs. The Competition
| Properties | SYRE | ABCL | ARDX | CLDX |
|---|---|---|---|---|
| Market Cap | $6.17B | $2.06B | $1.31B | $2.55B |
| Shares Outstanding | $60.4M | $305.38M | $247.03M | $66.54M |
| P/E Ratio | -46.82 | -14.04 | -22.53 | -8.97 |
| EPS | -0.52 | -0.47 | -0.24 | -4.26 |
| Day Low | 95.1351 | 6.62 | 5.02 | 37.615 |
| Day high | 102.62 | 6.93 | 5.31 | 38.675 |
| Year Low | 14.505 | 2.745 | 4.075 | 19.72 |
| Year High | 105.09 | 8.44 | 8.4 | 40.3 |
| Average Price 50 | 81.3177 | 5.8274 | 5.9169 | 33.2452 |
| Average Price 200 | 47.45422 | 4.4766 | 6.03998 | 29.07195 |
| Volume | 1.52M | 3.72M | 2.67M | 480.65K |
| Average Volume | - | - | - | - |